PMID: 7581350Aug 1, 1995Paper

The evolution of the clinician-scientist model of neurological rehabilitation

Brain Injury : [BI]
M D Peters, A McLean

Abstract

Over the past three or four decades two treatment technologies have been evolving in parallel, recently to some extent merging. The first of these technologies is behaviour analysis, with its emphasis on identification and manipulation of variables external to the individual as controlling agents. The second is neurological rehabilitation, with a characteristic focus of resources on recovery of function following neurological damage. The histories of both of these technologies are similar in that they emerged from basic laboratory research with non-human subjects, followed by extension of findings to research with humans, culminating in widespread formal application of results. The past 5 years have seen a convergence of behaviour analytic and neurological rehabilitation techniques resulting in major shifts in treatment service delivery systems. We briefly chronicle the emergence of these two technologies from their basic underpinnings through world-wide use. Further, discussion is provided describing our and others' experience with the combining of behaviour and neurological rehabilitation. Finally, we give an account of an innovative neurological rehabilitation service delivery system designed to deliver effective cost-effici...Continue Reading

References

Jul 1, 1992·Brain Injury : [BI]·M D PetersM McCormick
Jan 1, 1991·Rehabilitation Nursing : the Official Journal of the Association of Rehabilitation Nurses·M Whitman
Oct 1, 1990·Brain Injury : [BI]·T M McMillanR J Greenwood
Apr 1, 1990·Brain Injury : [BI]·A ZenciusS Hough
Nov 1, 1973·Behaviour Research and Therapy·R M Foxx, N H Azrin
Jun 1, 1967·Canadian Journal of Psychology·J R Millenson, D P Hendry
Oct 1, 1960·Journal of the Experimental Analysis of Behavior·R ORLANDO, S W BIJOU
Oct 1, 1960·Journal of Clinical Psychology·H C RICKARDR F HORNER
Oct 1, 1959·Journal of the Experimental Analysis of Behavior·T AYLLON, J MICHAEL
Jul 1, 1964·Journal of the Experimental Analysis of Behavior·T AYLLON, N H AZRIN
Oct 1, 1969·Journal of Applied Behavior Analysis·G W Schmidt, R E Ulrich
Jan 1, 1969·Journal of Applied Behavior Analysis·R G Wahler
Jan 1, 1961·Journal of the Experimental Analysis of Behavior·S W Bijou, R Orlando

❮ Previous
Next ❯

Citations

Oct 3, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Sarah E Chard
Jun 3, 2009·Developmental Disabilities Research Reviews·Keith J Slifer, Adrianna Amari
Oct 30, 2004·Laterality·T Helland, A Asbjørnsen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.